Cargando…
Environmental impact of inhalers for respiratory diseases: decreasing the carbon footprint while preserving patient-tailored treatment
Patients with asthma and Chronic Obstructive Respiratory Disease (COPD) rely on three main device classes for inhalation therapy: metered-dose inhalers (MDIs), dry powder inhalers (DPIs) and soft-mist inhalers (SMIs). The carbon footprint (CF) of these inhalers differs with MDIs having a higher impa...
Autores principales: | Panigone, Sara, Sandri, Federica, Ferri, Rossella, Volpato, Andrea, Nudo, Elena, Nicolini, Gabriele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173981/ https://www.ncbi.nlm.nih.gov/pubmed/32238349 http://dx.doi.org/10.1136/bmjresp-2020-000571 |
Ejemplares similares
-
Reducing carbon footprint of inhalers: analysis of climate and clinical implications of different scenarios in five European countries
por: Pernigotti, Daniele, et al.
Publicado: (2021) -
Costs of switching to low global warming potential inhalers. An economic and carbon footprint analysis of NHS prescription data in England
por: Wilkinson, Alexander J K, et al.
Publicado: (2019) -
Health-care Resource Requirements and Potential Financial Consequences of an Environmentally Driven Switch in Respiratory Inhaler Use in England
por: Attar-Zadeh, Darsuh, et al.
Publicado: (2021) -
Impact of changes to reimbursement of fixed combinations of inhaled corticosteroids and long-acting β(2)-agonists in obstructive lung diseases: a population-based, observational study
por: Björnsdóttir, U S, et al.
Publicado: (2014) -
A retrospective database study comparing treatment outcomes and cost associated with choice of fixed-dose inhaled corticosteroid/long-acting β(2)-agonists for asthma maintenance treatment in Germany
por: Aballéa, S, et al.
Publicado: (2008)